2,866
Views
5
CrossRef citations to date
0
Altmetric
Review Article

Organoboronic acids/esters as effective drug and prodrug candidates in cancer treatments: challenge and hope

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Article: 2220084 | Received 10 Jan 2023, Accepted 26 May 2023, Published online: 15 Jun 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Levente Kollár, Katarina Grabrijan, Martina Hrast Rambaher, Krištof Bozovičar, Tímea Imre, György G. Ferenczy, Stanislav Gobec & György M. Keserű. (2024) Boronic acid inhibitors of penicillin-binding protein 1b: serine and lysine labelling agents. Journal of Enzyme Inhibition and Medicinal Chemistry 39:1.
Read now

Articles from other publishers (4)

Simona Butan, Veronica Filimon & Alexandra V. Bounegru. (2024) Human health impact and advanced chemical analysis of fructoborates: a comprehensive review. Chemical Papers.
Crossref
Simone Giovannuzzi, Anna Nikitjuka, Bruna Rafaela Pereira Resende, Michael Smietana, Alessio Nocentini, Claudiu T. Supuran & Jean-Yves Winum. (2024) Boron-containing carbonic anhydrases inhibitors. Bioorganic Chemistry 143, pages 106976.
Crossref
John Gehris, Charlie Ervin, Charlotte Hawkins, Sydney Womack, Amelia M. Churillo, Jonathan Doyle, Albert J. Sinusas & Francis G. Spinale. (2024) Fibroblast activation protein: Pivoting cancer/chemotherapeutic insight towards heart failure. Biochemical Pharmacology 219, pages 115914.
Crossref
Sofia A. G. Monteiro, Pedro M. P. Gois & João P. M. António. (2023) Boronic Acids and Beyond: ROS-Responsive Prodrugs as Tools for a Safer and More Effective Cancer Chemotherapy. Synlett 34:18, pages 2129-2158.
Crossref